Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction

BACKGROUND AND PURPOSE: Up to 50–60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Baselet, Bjorn, Driesen, Ronald B., Coninx, Emma, Belmans, Niels, Sieprath, Tom, Lambrichts, Ivo, De Vos, Winnok H., Baatout, Sarah, Sonveaux, Pierre, Aerts, An
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082323/
https://ncbi.nlm.nih.gov/pubmed/32231569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00268
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki